07/11/2025
4:25 PM | 5AM Opportunities I , LLC (0001790778) (Reporting)
5AM Opportunities I, L.P. (Reporting)
5AM Partners V, LLC (Reporting)
5AM Ventures V, L.P. (Reporting)
Entrada Therapeutics (Issuer)
ROCKLAGE SCOTT M (Reporting)
Schwab Andrew J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2025
4:27 PM | Entrada Therapeutics (Issuer)
PARMAR KUSH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2025
4:02 PM | 5AM Ventures V, L.P. (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2025
4:04 PM | 5AM Opportunities I, L.P. (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2025
7:32 PM | 5AM Opportunities I , LLC (0001790778) (Reporting)
5AM Opportunities I, L.P. (Reporting)
5AM Partners V, LLC (Reporting)
5AM Ventures V, L.P. (Reporting)
Entrada Therapeutics (Issuer)
ROCKLAGE SCOTT M (Reporting)
Schwab Andrew J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
7:33 PM | Entrada Therapeutics (Issuer)
PARMAR KUSH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2025
4:06 PM | 5AM Ventures V, L.P. (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/30/2025
4:09 PM | 5AM Opportunities I, L.P. (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/27/2025
4:05 PM | 5AM Opportunities I, L.P. (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2025
3:32 PM | Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
| Form 4/A | |
06/12/2025
7:04 AM | Chapman Gina (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TRDA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Entrada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/12/2025
7:06 AM | Entrada Therapeutics (Issuer)
Zeiher Bernhardt G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
7:07 AM | Entrada Therapeutics (Issuer)
Thistle Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
7:08 AM | Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
7:10 AM | Entrada Therapeutics (Issuer)
PARMAR KUSH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
3:08 PM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2025
7:11 AM | Entrada Therapeutics (Issuer)
Radhakrishnan Maha (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/03/2025
7:13 AM | Entrada Therapeutics (Issuer)
Radhakrishnan Maha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
6:45 AM | Entrada Therapeutics (Filer)
| Form DEFA14A | |
06/03/2025
6:05 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2025
11:28 AM | Entrada Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
05/08/2025
6:03 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
6:09 AM | Entrada Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2025
6:00 AM | Entrada Therapeutics (Filer)
| Form DEF 14A | |
04/25/2025
6:06 AM | Entrada Therapeutics (Filer)
| Form DEFA14A | |
04/25/2025
6:12 AM | Entrada Therapeutics (Filer)
| Form ARS | |
04/04/2025
3:34 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2025
6:08 AM | Entrada Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/24/2025
6:06 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2025
3:32 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
6:02 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
6:07 AM | Entrada Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
6:16 AM | Entrada Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/24/2025
6:02 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
2:47 PM | Entrada Therapeutics (Subject)
ROCHE FINANCE LTD (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
10:25 AM | Entrada Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G | |
02/03/2025
6:05 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
4:00 PM | Entrada Therapeutics (Issuer)
EVNIN LUKE (Reporting)
Foley Todd (Reporting)
GADICKE ANSBERT (Reporting)
MPM Asset Management Investors BV2014 LLC (Reporting)
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC (Reporting)
MPM BioVentures 2014 GP LLC (Reporting)
MPM BioVentures 2014 LLC (Reporting)
MPM BioVentures 2014, L.P. (Reporting)
MPM BIOVENTURES 2018 , L.P. (0001729504) (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
4:00 PM | Entrada Therapeutics (Issuer)
MPM BioVentures 2018 GP LLC (Reporting)
MPM BioVentures 2018 LLC (Reporting)
MPM BIOVENTURES 2018, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:24 PM | Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:26 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The $7 company helping Nvidia build the world’s first trillion-dollar robot … (Ad) Michael Robinson has been at the forefront of the technology market for over 40 years.
Spotting some profitable trends in tech … well ahead of Wall Street.
Like when he called Nvidia at a mere 80 cents a share.
Or Bitcoin when it was trading for just $300.
Throughout his illustrious career …
Michael has given his followers almost 150 different chances to register triple-digit gains. Now he's identified his next potential winner. Click here to find out more. |
11/13/2024
3:47 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
3:49 PM | Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
6:06 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
6:12 AM | Entrada Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/18/2024
3:31 PM | Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
3:25 PM | Entrada Therapeutics (Subject)
Sethuraman Natarajan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024
3:32 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
3:32 PM | Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
3:33 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
3:34 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
3:27 PM | Entrada Therapeutics (Subject)
WENTWORTH KORY JAMES (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2024
3:19 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
5:46 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
5:49 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
5:47 PM | Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
5:48 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:33 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
3:25 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
6:05 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
6:14 AM | Entrada Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
